spacer
home > pmps > spring 2017 > under control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Under Control

A controlled substance is a drug or chemical whose manufacture, possession or distribution is highly regulated by the government and subject to legislative control. They include illegal drugs, prescription medications and chemicals considered as precursors to the production of illegal drugs. These are all believed to cause harm to an individual if not used properly. Their manufacture and distribution are closely monitored by the United Nations (UN).

The construction of an international legal framework for controlled drugs has gone through several stages of development since the 1920 alcohol prohibition in the US. In 1961, the Single Convention on Narcotic Drugs was established as a universal system to limit the cultivation, production, distribution, trade, use and possession of narcotic substances strictly for medical and scientific purposes, with special attention to those produced from plants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rich Nelson is the Distribution Services Manager for PCIís Clinical Services group, working with clients to provide seamless global distribution of their investigational products. He joined the company in 2012 after seven years with Fisher Clinical Services, having supported both global distribution for investigational products, as well as interactive voice response solutions. Rich is certified in Lean Six Sigma/continuous improvement, including as a Small Group Facilitor/ Corporate Trainer, and is a graduate of Monmouth University, US.
spacer
Rich Nelson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Aptus Clinical enters into a global partnership agreement with Artelo Biosciences

We are delighted to announce that Aptus Clinical has entered into an agreement with Artelo Biosciences to provide clinical development support the re-purposing of its high-potency dual cannabinoid agonist ART27.13 in oncology.
More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). Itís about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

RDD Asia 2018

14-15 November 2018, Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement